Tenet Q3 adj EPS $1.44; raises FY 2023 EBITDA outlook to $3.365-3.465B

TENET HEALTHCARE CORP

2023-Q3 EPS reported $3.41 revenue$15,169,000,000

Net income $101M ($0.94 GAAP); adjusted diluted EPS $1.44 vs $1.42 YoY.
Revenue $5,066M (+5.5% YoY); consolidated Adj. EBITDA $854M (+$13M YoY).
Ambulatory Care Adj. EBITDA $370M (+16.0% YoY); same-facility surgical cases +4.1%.
FY 2023 Adj. EBITDA outlook raised to $3.365-3.465B; free cash flow $327M in Q3.
Repurchased 1.5M shares for $90M in nine months; net debt/EBITDA 4.08x.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TENET HEALTHCARE CORP reported quarter ended September 30, 2023 results: revenue $5,066, net income $101 million, EPS $0.94. Guidance raised.

Period: quarter ended September 30, 2023
Revenue: $5,066
Net income: $101 million
EPS: $0.94
Guidance: raised
Result: reported results

Exact text from the filing

2022 are as follows: Three Months Ended September 30, Nine Months Ended September 30, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,066 $4,801 $15,169 $14,184 Net income available to Tenet common shareholders from continuing operations $101 $131 $367 $308 Net income available to Tenet common shareholders from

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

TENET HEALTHCARE CORP filing history →

Source: SEC EDGAR

accession 0000070318-23-000054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.